Company: WKSP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023334
Chunk: 118

Company: Worksport Ltd
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 3
Chunk 118
---
 Securities Act and Regulation A.

(b)
Use of Proceeds

Not
applicable.

(c)
Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

Item
3. Defaults Upon Senior Securities

None.

Item
4. Mine Safety Disclosures

Not
applicable.

Item
5. Other Information

Securities
Trading Plans

During
the six months ended June 30, 2025, none of our Section 16 officers or directors (as defined in Rule 16a-1(f) of the Exchange Act)
adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy
the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as
defined in Section 408(c) of Regulation S-K).

Subsequent
Events

    On
    July 12, 2025, the Company granted employees an aggregate of 91,940 stock options priced at the closing stock price on July 11, 2025,
    vesting 50% at the end of the following two annual anniversaries from grant date, and expiring 10 years from grant date. Under these
    same terms, the Company granted directors an aggregate of 10,000 stock options.
     
    On
    July 12, 2025, the Company granted Steven Rossi 215,000 stock options priced at the closing stock price on July 11, 2025, vesting
    50% at the end of the following two annual anniversaries from grant date, and expiring 10 years from grant date.
     
    On
    July 12, 2025, the Company granted a director 50,000 stock options priced at the closing stock price on July 11, 2025, vesting pursuant
    to a performance milestone, and expiring 10 years from grant date.
     
    On
    July 12, 2025, the Company granted a consultant 76,500 stock options priced at the closing stock price on July 11, 2025, vesting
    pursuant to performance milestones, and expiring 10 years from grant date.
     
    On
    July 14, 2025 the Company signed a lease agreement for 1,992 square feet of office space to be used as an R&D